Comparative analysis of PIM criteria and drug labels in the elderly.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 197, doi. 10.1007/s00228-021-03262-2
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2022 AND VI 78 AND IP 2
Results: 18
1
2
Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 293, doi. 10.1007/s00228-021-03236-4
- By:
- Publication type:
- Article
3
Bevacizumab and aflibercept in second-line metastatic colorectal cancer: 12 years of experience.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 287, doi. 10.1007/s00228-021-03235-5
- By:
- Publication type:
- Article
4
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 191, doi. 10.1007/s00228-021-03234-6
- By:
- Publication type:
- Article
5
Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 181, doi. 10.1007/s00228-021-03226-6
- By:
- Publication type:
- Article
6
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 227, doi. 10.1007/s00228-021-03233-7
- By:
- Publication type:
- Article
7
Mega randomized clinical trials: a definitive solution or a double-edged sword?
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 305, doi. 10.1007/s00228-021-03230-w
- By:
- Publication type:
- Article
8
Response to letter regarding the article "Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age".
- Published in:
- 2022
- By:
- Publication type:
- Letter
9
Association between the use of hormonal contraceptives and risk of gallstone disease.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
10
Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 215, doi. 10.1007/s00228-021-03224-8
- By:
- Publication type:
- Article
11
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 259, doi. 10.1007/s00228-021-03232-8
- By:
- Publication type:
- Article
12
Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 171, doi. 10.1007/s00228-021-03222-w
- By:
- Publication type:
- Article
13
Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 279, doi. 10.1007/s00228-021-03221-x
- By:
- Publication type:
- Article
14
Population pharmacokinetics of cefotaxime in intensive care patients.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 251, doi. 10.1007/s00228-021-03218-6
- By:
- Publication type:
- Article
15
Drug-related deaths among inpatients: a meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 267, doi. 10.1007/s00228-021-03214-w
- By:
- Publication type:
- Article
16
Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 205, doi. 10.1007/s00228-021-03204-y
- By:
- Publication type:
- Article
17
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 237, doi. 10.1007/s00228-021-03173-2
- By:
- Publication type:
- Article
18
Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 159, doi. 10.1007/s00228-021-03213-x
- By:
- Publication type:
- Article